Navigation Links
Elixir Pharmaceuticals Presents Additional Preclinical Data,Demonstrating the Potential of Ghrelin Antagonism to Regulate,Metabolism, Body Weight and Glycemic Control

s undergone extensive clinical development demonstrating the product's ability to safely and effectively treat Type 2 diabetes.

Elixir has also developed expertise and a broad IP portfolio of more than twenty patents and patent applications related to the Sirtuin class of proteins, including small molecular weight SIRT1 activators and inhibitors. The Company's own R&D efforts and those of its numerous research partners utilizing modulators of SIRT1 (a human sirtuin) have significantly extended the SIRT knowledge base in recent years. Elixir is also actively pursuing drug discovery efforts focused on other key targets, such as AMP-activated kinase (AMPK) and the INDY gene, both of which have been implicated in the regulation of aging and metabolism in a variety of organisms.

More information about Elixir is available at http://www.elixirpharm.com/

Contact

Elixir Pharmaceuticals
William Heiden, 617-995-7000
or
Burns McClellan for Elixir Pharmaceuticals, 212-213-0006
Media:
Justin Jackson, jjackson@burnsmc.com
Jason Farber, jfarber@burnsmc.com
or
Investors:
Juliane Snowden, jsnowden@burnsmc.com
Nicki Kahner, nkahner@burnsmc.com


'"/>




Page: 1 2 3 4

Related medicine technology :

1. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting
2. Elixir Pharmaceuticals Announces Clinical Data at American Diabetes Association Conference Highlighting Ability of Glufast to Maintain Glycemic Control in Patients with Type 2 Diabetes
3. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
7. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
8. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
10. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
11. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
Post Your Comments:
(Date:5/27/2015)... 27, 2015 Biomedical Catalyst ... Target Prostate Cancer  Crescendo Biologics Limited ... drug conjugate (ADC) programme with the support of ... agency, Innovate UK. This feasibility award will enable ... (HDCs) a novel product format based on Crescendo,s ...
(Date:5/26/2015)... 26, 2015  AbbVie (NYSE: ABBV ) ... study of its investigational, all-oral, interferon (IFN)- and ... at the Annual Meeting of the Japan Society ... . 1 GIFT-I evaluated genotype 1b (GT1b) ... with and without cirrhosis, who were either treatment-naïve ...
(Date:5/26/2015)... May 26, 2015 Depomed, Inc. (NASDAQ: DEPO ... healthcare conferences in June. The 2015 Jefferies ... Jefferies conference is scheduled for 3:00 pm EDT (12:00 noon ... JMP Securities Life Sciences Conference in New York City.  The ... EDT (8:30 am PDT) Wednesday, June 24, 2015. ...
Breaking Medicine Technology:Crescendo Biologics Expands ADC Programmes with Innovate UK Funding Award 2AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 2AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 3AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 4AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 5AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 6Depomed To Present At Healthcare Conferences In June 2
... 2011 The board of directors of Eli Lilly and Company (NYSE: ... of 2011 of $0.49 a share on outstanding common stock. This is ... 2011 and brings the total annual dividend for 2011 to $1.96 per ... of record at the close of business on November 15, 2011. ...
... SPRING, Md., Oct. 17, 2011 The U.S. Food ... draft special controls guidance lowering the risk classification for ... Class II (moderate-risk). (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) ... to regulate a patient,s heartbeat until a permanent pacemaker ...
Cached Medicine Technology:FDA Proposes Lower Risk Classification, Special Controls for External Pacemakers 2FDA Proposes Lower Risk Classification, Special Controls for External Pacemakers 3
(Date:5/26/2015)... 2015 In celebration of Parker and Sons ... a discount on HVAC systems with a high Season Energy ... HVAC systems with a SEER rating around 15-16 can be ... For those unfamiliar with a SEER rating, it is essentially ... it measures the amount of energy expended by the actual ...
(Date:5/26/2015)... Degeneration of the white matter of ... types of Alzheimer’s disease (AD), including early-onset AD, according ... journal Radiology. , “Alzheimer’s is a gray matter ... study conducted at the Neuroimaging Research Unit, San Raffaele ... has a central role in how the disease strikes ...
(Date:5/26/2015)... (PRWEB) May 27, 2015 The world ... Dr. Delgado ’s quest to remain on the cutting ... to spotlight the many new additions to plastic surgery ... and cosmetic surgical procedures, with emphasis on facelifts and ... design is very user friendly and easy to navigate. ...
(Date:5/26/2015)... 2015 Mr. Gould and Mr. Ken Cochran, ... working together this week to ensure a smooth transition. ... executive leadership and strategy. Gary is familiar with East ... of Mr. Cochran. The Board of Trustees believe Mr. Gould’s ... strategies implemented over the past few years. , “Our ...
(Date:5/26/2015)... Over 700 doctors, nutritionists, nurses, and public health ... of the U.S. Department of Agriculture and the U.S. ... embrace the 2015 Dietary Guidelines Advisory Committee’s recommendations to ... economic prosperity, and our nation’s food security. , Leaders ... Dr. David Katz, founding director of the Yale University ...
Breaking Medicine News(10 mins):Health News:Parker and Sons Recounts its Path to Success 2Health News:RSNA: Imaging Test May Identify Biomarker of Alzheimer’s Disease 2Health News:RSNA: Imaging Test May Identify Biomarker of Alzheimer’s Disease 3Health News:Miguel Delgado, M.D. Launches Two New Plastic Surgery Websites 2Health News:Miguel Delgado, M.D. Launches Two New Plastic Surgery Websites 3Health News:700 Doctors, Health Professionals, Including the American College of Lifestyle Medicine, Support Dietary Guidelines Message to Eat Less Meat, More Plants 2Health News:700 Doctors, Health Professionals, Including the American College of Lifestyle Medicine, Support Dietary Guidelines Message to Eat Less Meat, More Plants 3
... it is working on four vaccines, including those for ... are currently working on four vaccines for anthrax, dengue, ... for anthrax vaccine have been completed, which is ready ... Jain told reporters here today., ,The company would ...
... lesions, that typically precede cervical cancer is much higher ... papillomavirus (HPV) than previously reported, according to a study ... & Prevention. ,Although doctors have known that ... can harbor multiple HPV types, this study is the ...
... at New South Wales central coast are in the process ... financial// support from the vaccine company in the US. ... immunise animals against the infection. ,As chlamydial infection ... for the past seven years to find a cure against ...
... with Publix Super Markets of Lakeland, Florida, are issuing ... Chip Cookie Dough. ,According to Maria Brous, ... "The chocolate chip dough may contain pecans. As a ... have been no reported cases of illness. Customers who ...
... study of women in the Nurses' Health Study has shown ... glaucoma (POAG), the most common form of glaucoma//, accounting for ... published in the July issue of the journal Ophthalmology. ... and Women's ,Hospital, Harvard School of Public Health and Harvard ...
... drugs used to reduce the levels of LDL cholesterol ... can cause serious muscle// damage. ,Health Canada ... Lipitor, Pravachol, Zocor, Crestor and Mevacor to include warnings ... patient safety information sheets. ,Statin drug users ...
Cached Medicine News:Health News:Higher Risk for Cervical Cancer Seen Among Women Infected with Multiple HPV Types 2Health News:Higher Risk for Cervical Cancer Seen Among Women Infected with Multiple HPV Types 3Health News:Type 2 Diabetes Increases the Risk of Glaucoma in Women 2
... The High Throughput Sorter RSD ... high volume laboratories in the field ... is not only of considerable speed ... optional Recapping Module can be integrated. ...
... System RCS 800 closes various plastic primary and ... way. Different tube heights and diameters can be ... be used for send-outs. The integration into other ... System RSD 800 and High Throughput Sorter RSD ...
... Decapping System DS 800 selectively removes closures from ... the barcode towards the rack opening in one ... integrated in PVT Systems like Sorting System RS ... Sorter RSD ProVolume and Aliquoting System RSD 800A. ...
... Nanogen offers reagents to detect sequences ... parainfluenza virus 1, 2 and 3; ... respiratory syncytial virus A and B. ... to create homebrew tests., ...
Medicine Products: